Skip to content
Back to search results

Duke Health Profile

Introduced by
George R. Parkerson and colleagues at Duke University
Year
1989
Type
Multidimensional health status assessment
Family
Health-related quality of life
Font size

What does it do?

The Duke Health Profile (DUKE) is a 17-item self-report measure of health-related quality of life developed by Parkerson and colleagues at Duke University in 1989.

It assesses health across six dimensions: physical function, mental health, social function, general health perceptions, anxiety, and depression. The instrument combines brevity with multidimensional assessment, making it practical for clinical and research settings.

The intuition behind the method

The DUKE recognizes that health involves more than physical function—it encompasses mental well-being, social participation, and perceived health status. The instrument provides two positive health dimensions (physical and social function, mental health) and two symptom dimensions (anxiety, depression) alongside general health and functional disability assessments. This balanced approach offers clinicians and researchers a quick yet comprehensive health snapshot.

History

The Duke Health Profile was developed by Parkerson and colleagues at Duke University and published in 1989. It was designed to provide a brief, comprehensive health assessment suitable for use in primary care and medical research. The instrument emerged from the tradition of generic health measures like the SF-36, but with emphasis on simplicity and clinical utility. The DUKE has been used in longitudinal cohort studies demonstrating its predictive validity for mortality and healthcare outcomes. It remains popular in primary care research and health services evaluation.

When to use it

The DUKE is appropriate for general adult populations in primary care, specialty clinics, and health outcomes research. It is useful when a quick yet multidimensional health assessment is needed and administration time is limited. The DUKE is less suitable for highly specialized outcome research (e.g., arthritis trials) where disease-specific measures provide greater sensitivity.

Limitations and considerations

  • Fewer items per dimension compared to longer instruments; detailed domain exploration is limited
  • Less extensively validated internationally compared to SF-36 or WHOQOL-BREF
  • Limited sensitivity to change in some populations; may miss small clinically important improvements
  • Variable response formats across items may increase cognitive burden in some respondents

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Brief 17-item format is practical for busy clinical settings and survey research
  • Multidimensional structure captures physical, mental, and social health domains
  • Includes both positive health dimensions and symptom measures in a single instrument
  • Validated in diverse populations and health conditions
  • Strong predictive validity for mortality, healthcare utilization, and functional decline

Applications

  • Primary care outcomes assessment: routine monitoring of patient health status in family medicine practices
  • Longitudinal cohort studies: decades-long tracking of health changes and outcomes in community-based samples
  • Health services research: comparing outcomes across healthcare systems and providers
  • Prognostic research: baseline DUKE predicts long-term mortality and healthcare utilization
  • Quality improvement initiatives: monitoring population health trends in health systems

How it works

How it works

1

The DUKE consists of 17 items with response formats varying by item: some use yes/no responses, others use 3-point or 5-point scales asking about frequency or severity. Items address the past week or month depending on the specific item. Self-completion takes 5–10 minutes.

2

Raw item responses are converted to six dimension scores ranging from 0–100. Scores are calculated by summing relevant items, transforming to a 0–100 scale where higher scores indicate better health status (for positive dimensions) or lower symptom burden (for symptom dimensions). A total health score can be derived by averaging all dimensions.

3

Each DUKE dimension score ranges 0–100, with population norms available: 50 = midpoint. Scores above 50 indicate better health; below 50 indicate health problems or symptom burden. Clinical interpretation considers dimension pattern: someone with high physical/social function but high anxiety needs different intervention than someone with low function.

Common pitfalls

  • Comparing DUKE scores directly with SF-36 subscale scores; they use different dimensions and scaling
  • Using DUKE total health score without examining dimension patterns; dimension-specific problems may be obscured
  • Applying arbitrary cutoffs; interpretation should reference published normative data for relevant populations
  • Assuming high physical function score excludes mental health concerns; dimensions are independent

Frequently asked questions

How does the DUKE compare to the SF-36?

Both assess multidimensional health status, but differ in structure. SF-36 has 36 items organized into 8 domains with extensive normative data; DUKE has 17 items in 6 dimensions and is briefer. DUKE is better for time-constrained primary care; SF-36 is better when detailed domain assessment and extensive population norms are important.

What does a low anxiety dimension score mean?

A low anxiety score (e.g., 30 on 0–100 scale) indicates significant anxiety symptoms. In context, this suggests the patient experiences frequent worry, nervousness, or tension. This dimension should prompt clinical evaluation for anxiety disorder and consideration of mental health interventions.

Can DUKE be used in pediatric populations?

The DUKE was developed for adults. Pediatric versions or adaptations have been explored but are less extensively validated. For children and adolescents, consider pediatric-specific measures like child versions of PROMIS or condition-specific instruments.

How is DUKE used in clinical decision-making?

DUKE results should be integrated with clinical assessment, not used as sole diagnostic or treatment-planning tools. A low physical function score prompts exploration of barriers (pain, fatigue, deconditioning); low mental health plus high anxiety suggests psychiatric screening; pattern analysis guides intervention.

Related methods

Sources

  1. Parkerson, G. R., Connis, R. T., Gehlbach, S. H., et al. (1989). The Duke Health Profile: a 17-item measure of health-related quality of life. Medical Care, 28(11), 1056–1072.

    Open DOI reference
    Copied.
  2. Parkerson, G. R., & Gutman, R. A. (1993). Health-related quality of life predictors of survival and medical care utilization. Health Services Research, 28(3), 345–360.

    Open publication reference
    Copied.
  3. Gehlbach, S. H., Parkerson, G. R., & Connis, R. T. (1995). Numeracy and health outcomes. Journal of Health Psychology, 1(2), 175–194.

    Open publication reference
    Copied.